Kappa Bioscience vitamin K2 granted EU novel food approval

Kappa Bioscience vitamin K2 granted EU novel food approval

Kappa Bioscience is now ready to launch its K2VITAL product range in the European markets for food supplements, fortified foods and food products for specific nutritional purposes.

Kappa Bioscience announced today that they have been granted novel food approval for their vitamin K2 as menaquinone-7 (K2VITALTM).

The Novel Food application was submitted to the German Food Safety Agency. Based on a positive German assessment, all the EU member states have acknowledged the novel food recommendation.

Kappa Bioscience is now ready to launch their K2VITAL™ product range in the European markets for food supplements, fortified foods and food products for specific nutritional purposes.

“This is a major achievement for all users of vitamin K2“, said CEO Egil Greve of Kappa Bioscience. “Our products represent a technological break-through in the vitamin sector and provide the market with vitamin K2 of the highest possible purity and functionality - for use in tablets, capsules and fortification of food products. This now allows food and DS manufactures to take vitamin K2 from a previous niche application into mainstream application due to a better cost-in-use proposition“, he added.

K2VITAL™ has been sold in the US and other selected markets since 2011. Kappa has a co-operation with Xsto Solutions for sales in the US DS segment and with DuPont, who acquired Danisco in May 2011, for the global food segment.

About Vitamin K2: Vitamin K is a group of fat soluble vitamins known to be critical in blood coagulation. Vitamin K is divided into K1 (clotting activity) and vitamin K2, which also has extra hepatic activities. Vitamin K2 as menaquinon-7 (MK-7) has the highest bioavailability and has proven effects on bone health (EFSA 13.1 Claim) and cardiovascular health. Vitamin K2 acts as co-factor for proteins involved in calcium metabolism.

 

About K2VITAL

K2VITAL™ is Kappa Bioscience’s commercial product range containing pure,
all-trans  menaquinone-7 (MK-7).  It is available in powder, granular and liquid form, each in various concentrations. K2VITAL™ is the most bio-available and cost effective form of vitamin K2 available for food and supplementation. This key nutrient offers significant health benefits for humans.

About Kappa Bioscience: Kappa Bioscience is the innovative leader and first mover within high purity, all-trans vitamin K2 as menaquinone-7 (MK-7). Kappa Bioscience is a Norwegian based entity with substantial resources and knowledge about vitamins and vitamin K2 in particular. Kappa Bioscience is currently the only vendor with vitamin K2 as pure MK-7 in various formulations, following a traditional vitamin production process with proprietary and innovative new steps. For further information, visit http://www.kappabio.com

 

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish